首页> 外国专利> Targeted hydrophobic anti-tumor drug nanoformulation and preparation method thereof

Targeted hydrophobic anti-tumor drug nanoformulation and preparation method thereof

机译:靶向疏水性抗肿瘤药物纳米型纳米型和制备方法

摘要

The present invention relates to a targeted hydrophobic anti-tumor drug nanoformulation, which comprises a hydrophobic anti-tumor drug and a carrier with a mass ratio of 1:4-32.5, wherein the carrier is composed of 37.5-95.3 wt % albumin and 4.7-62.5 wt % hyaluronic acid-albumin conjugate, and the hyaluronic acid-albumin conjugate is prepared by albumin and hyaluronic acid with a molar ratio of 1:1-20. A preparation method of the nanoformulation comprises: preparing hyaluronic acid-albumin conjugate; formulating carrier solution; formulating drug solution; and preparing nanoformulation. The nanoformulation has even particle size distribution and good dispersibility, is stable without aggregating. The particle size of the lyophilized nanoformulation after being redissolved substantially remains unchanged, the yield of the nanoformulation is high and the efficacy is good after being filtered by a millipore filter (0.22 μm).
机译:本发明涉及目标疏水性抗肿瘤药物纳米型纳米型,其包含疏水性抗肿瘤药物和质量比为1:4-32.5的载体,其中载体由37.5-95.3wt%白蛋白和4.7组成 -62.5wt%透明质酸 - 白蛋白缀合物,并且透明质酸 - 白蛋白缀合物通过白蛋白和透明质酸制备,摩尔比为1:1-20。 纳米型测量的制备方法包括:制备透明质酸 - 白蛋白缀合物; 配制载体溶液; 配方药物溶液; 并制备纳米造型。 纳米造型率甚至具有粒度分布和良好的分散性,稳定而不聚集。 在重新溶解之后冻干纳米造型率的粒度基本保持不变,纳米型锻造的产率为高,并且在用毫流过滤器(0.22μm)过滤后功效良好。

著录项

  • 公开/公告号US11090268B2

    专利类型

  • 公开/公告日2021-08-17

    原文格式PDF

  • 申请/专利权人 AC PHARMACEUTICALS CO. LTD;

    申请/专利号US201616060103

  • 申请日2016-11-24

  • 分类号A61K9/19;A61K9/51;A61K31/337;A61K31/436;A61K31/4745;A61K31/675;A61K31/704;A61K38/13;A61K38/14;

  • 国家 US

  • 入库时间 2022-08-24 20:38:09

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号